Deciphex

Deciphex

Private
DublinHealthcare & Life Scienceshttps://www.deciphex.com/

Last Round

Debt

Oct 1, 2025

Total Funding Raised

$126.12M

Momentum Score

25 /100

Company Overview

Deciphex is a health technology company that develops artificial intelligence-powered digital pathology software and provides services to accelerate pathology diagnostics for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Drug Discovery, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Marketplace Commission, Government Contracts

AI Layer

Application

Keywords

digital pathologyAI pathologypathologist networkpreclinical pathologyclinical pathologycomputational pathologyremote pathologytelepathologypathology SaaSon-demand pathologypathology image analysisdrug safety assessmenttoxicology studiespathology marketplacewhole slide imagingslide scanning serviceAI as a Service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deciphex Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deciphex Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtOct 1, 2025
Series CJan 7, 2025
Series CJan 7, 2025
DebtOct 16, 2023
Series B ExtensionJan 25, 2023
Series B
May 19, 2022

Key People

Founding team and executive leadership

Andrea Rizzini

Chief Technology Officer

Executive Team

Mairin Rafferty

Chief Operations Officer (COO)

Executive Team

Ciara Mullin

Chief People Officer (CPO)

Executive Team

Deciphex Investors

Notable investors and investment history

InvestorRounds
ACT Venture CapitalSeries C, Series B Extension, Series A, Seed, Series B
Claret Capital PartnersDebt
Seroba Life SciencesSeries C, Series B Extension
Inova Personalized Health AcceleratorSeed
NextSteps CapitalSeries C, Series B, Series B Extension, Series A, Seed
University College DublinGrant
EIC AcceleratorGrant

Deciphex Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deciphex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deciphex's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range177
Year Founded2017
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.